Short answer: We judge foods by the quality of the studies behind them, putting meta-analyses and trials above cohort studies, and those above animal and lab work. We look at seven brain pathways, sort foods into brain-positive, neutral or brain-negative, and put whole diets ahead of supplements. Each article carries an evidence grade for its main claim.

This page explains how we evaluate foods, nutrients and diets for brain health. In short, we weigh each claim by the kind of study behind it, ask which brain systems a food affects, and sort foods into three groups. Our core position is food first: whole eating patterns matter more than single nutrients.

Why we use a framework

Brain-health advice is often built on a single rodent study or a small pilot trial. Supplement makers promise sharper focus and better memory, and solid findings get lost in the noise. We want a method that is open and repeatable, so a reader can see why we reached a conclusion.

There are two common approaches, and each has a gap. The single-study approach brands a food a “brain food” after one positive result, whatever the dose or study population. The pattern approach, such as the Mediterranean or MIND diet, is well supported at the population level but doesn’t always explain why specific foods are included.

We try to combine them. We look at which brain pathways a food affects and how strong the evidence is for each effect, then place that within the whole diet. That explains why blueberries appear on every brain-health list, and why a blueberry extract capsule is not a substitute for a diet rich in many polyphenol sources.

Three principles guide this:

  • Show the reasoning. Each rating should trace back to the studies behind it and the biological mechanism proposed, with sources listed on each article.
  • Grade the evidence. A meta-analysis of twelve randomized trials tells you something very different from a single survey or a cell-culture experiment. Each article carries an overall evidence grade for its main claim, on a four-tier scale (Strong, Moderate, Preliminary, Insufficient; see how we grade evidence). The text should say where the evidence is strong and where it is preliminary.
  • Be specific. We ask which cognitive functions a food affects, through which pathways, at what doses and in whom. A food that supports serotonin may matter for mood but not working memory. A nutrient that helps older adults with low levels may do little for a well-nourished 25-year-old.

How we rank evidence

From strongest to weakest:

  1. Meta-analyses and systematic reviews. A meta-analysis pools data from several studies, usually randomized trials, to estimate an overall effect. Done well (with a predefined search, checks for bias and for unpublished null results), these are the strongest evidence in nutrition science. We use them as the main basis for our strongest claims. An example is the evidence for EPA-predominant omega-3 formulas in depression. By contrast, trials of DHA for cognition in older adults have been mixed, so we treat that evidence as weaker.
  2. Randomized controlled trials. Randomly assigning people to a diet or a control is the best way to show cause and effect. Among trials, we weigh most heavily those with enough participants, relevant outcomes, a suitable control group and enough time; dietary effects on cognition usually take months to show. Any single trial can be a false positive or false negative, so when only one exists we call it promising and say it needs replication.
  3. Prospective cohort studies. Studies such as the Framingham Heart Study, the Nurses’ Health Study and the Rush Memory and Aging Project follow thousands of people for years. They show associations, not cause, because diet is tangled up with income, education, exercise, genes and other habits. When cohort data stand alone without trial support, we say so.
  4. Mechanistic and preclinical studies. Cell cultures, animal studies and human biomarker studies help explain why a food might work. They don’t show that the effect happens in people eating normal amounts. A compound that raises BDNF in a rat’s brain at drug-like doses may not do the same in a person eating a normal portion. We never base a food rating on preclinical data alone.
  5. Expert opinion and traditional use. These can suggest ideas but aren’t scientific evidence. We mention them only for context, never as a basis for a rating.

The seven brain pathways

We look at how a food or nutrient affects seven systems through which diet is known to influence the brain.

1. Acetylcholine. This chemical messenger is central to memory, attention and learning. The acetylcholine system is among the first to decline in Alzheimer’s, and the most widely used class of Alzheimer’s drugs (cholinesterase inhibitors such as donepezil) works by boosting it. The main dietary factor is choline, found in eggs, liver and fish. Huperzine A, a plant extract sold as a supplement, slows acetylcholine breakdown and can interact with Alzheimer’s medicines.

2. Dopamine. Dopamine drives motivation, reward, planning and working memory. Diet affects it through tyrosine (from protein-rich foods) and the nutrients needed to make dopamine, such as iron, vitamin B6 and folate.

3. Serotonin. Serotonin regulates mood, sleep and appetite. Making it requires tryptophan, vitamin B6 and enough carbohydrate to help tryptophan reach the brain. About 90 percent of the body’s serotonin is made in the gut, so gut health matters here too.

4. BDNF. Brain-derived neurotrophic factor is a protein that helps nerve cells survive, grow and form new memories. Levels fall with age and are lower in depression and Alzheimer’s. Omega-3 fats, polyphenols from berries and cocoa, calorie restriction and some micronutrients may raise it. We look for effects in human studies, though much of the BDNF evidence comes from animals.

5. Neuroinflammation. Chronic low-grade inflammation in the brain is increasingly seen as a driver of cognitive decline, brain degeneration and mood disorders. We rate fatty fish, extra-virgin olive oil, berries and leafy greens on their ability to lower inflammation markers, and ultra-processed foods, refined sugar and excess seed oils for the opposite. More in our guide to the anti-inflammatory diet.

6. Oxidative stress. The brain uses about 20 percent of the body’s oxygen despite being 2 percent of body weight. Its fats are easily damaged and its antioxidant defenses are modest. We don’t rely on crude antioxidant scores such as ORAC, which have limited clinical relevance. We look for evidence that compounds such as flavonoids, carotenoids, vitamin E and selenium reach the brain in active form and protect it in human or strong preclinical studies.

7. Blood sugar and blood vessels. The brain depends on a steady supply of glucose. Both chronically high blood sugar and sharp swings impair thinking. Type 2 diabetes is linked to a substantially higher risk of dementia, and insulin resistance, even without diabetes, is linked to a smaller hippocampus and poorer memory. We rate foods on their effect on blood sugar, insulin sensitivity and blood vessel health. See our page on blood sugar and brain function.

How we classify foods

Brain-positive. There is consistent, replicated evidence, ideally from meta-analyses or several trials and backed by a plausible mechanism, that the food supports cognition or brain health through one or more pathways. Examples: fatty fish (DHA and EPA), eggs (choline), berries (anthocyanins), leafy greens (folate, lutein and vitamin K), nuts (vitamin E, polyphenols and healthy fats) and extra-virgin olive oil (oleocanthal). Brain-positive doesn’t mean “eat unlimited amounts”. It means a net benefit as part of a reasonable diet.

Neutral. The evidence shows no clear positive or negative effect at normal intakes. Most whole, minimally processed foods fall here. Neutral doesn’t mean unimportant: a varied whole-food diet is the base that brain-positive foods work within.

Brain-negative. There is consistent evidence, from meta-analyses, trials or large cohorts with a plausible mechanism, that regular intake harms cognition or raises the risk of brain disease. The best-supported example is ultra-processed food. Large cohort studies, including the UK Biobank (Li 2022) and the Brazilian ELSA-Brasil study (Gonçalves 2023), have linked higher intake to higher dementia risk and faster cognitive decline. This evidence is observational. Other brain-negative items are excess added sugar and excess alcohol, which harms the brain at moderate-to-high intake despite outdated claims about light drinking. Trans fats are another; they promote inflammation and, in animal studies, lower brain DHA. The harm depends on how much and for how long.

How the articles fit together

  • Nutrient articles (such as omega-3, choline or creatine) cover one compound in depth: mechanism, trials, food sources, doses studied and who might benefit.
  • Diet articles (such as MIND or Mediterranean) ask whether a whole eating pattern’s outcomes support its claims.
  • Condition articles (such as brain fog or ADHD) start from an outcome and work back to the foods and nutrients with the best evidence for it.

When the same food shows up across many lines of research, as omega-3s do in depression, cognitive aging, inflammation and the MIND diet, that convergence is informative. The framework is meant to reward it and to discount isolated, unreplicated findings.

Food first, supplements second

Whole foods are the main way to feed the brain. Supplements are useful in specific situations but never replace a good diet. Three reasons:

  • The food matrix. Nutrients in food come with fiber, fats and other compounds that affect how well they are absorbed and how they act. Lycopene from tomatoes cooked in olive oil is absorbed better than lycopene in a capsule. An egg’s choline comes with protein, lutein and vitamin D.
  • Pattern evidence. Mediterranean, MIND and similar diets have been linked to lower dementia risk and slower cognitive decline in many large observational studies. Trials are fewer and mixed; the 2023 MIND diet trial was null. Single-nutrient supplement trials have mostly been disappointing.
  • False security. A fish oil capsule and a multivitamin don’t offset a diet dominated by ultra-processed food.

Supplements do have a role:

  • Documented deficiency. If blood work or a diet review shows low intake of a key nutrient, such as vitamin B12, vitamin D or choline, supplementing is warranted and often necessary.
  • Specific groups. Vegans need a reliable B12 source (supplements or fortified foods) and may consider algae-based omega-3s. Many pregnant people get less choline than recommended and should discuss supplements with their doctor or midwife. Some older adults may need vitamin D. The adult upper limit is 4,000 IU a day, and current Endocrine Society guidance (2024) advises against routine testing and high doses in healthy adults.
  • Doses food can’t easily reach. Depression trials that found a benefit used EPA-predominant formulas at up to about 1 g a day, more than most people get from fish. Fish oil can increase bleeding risk with anticoagulant or antiplatelet drugs. Doses above about 1 g a day have been linked to a higher risk of atrial fibrillation in trials.
  • Creatine. Small trials suggest possible cognitive benefits, especially under sleep deprivation or in vegetarians, at doses (typically 3–5 g a day in studies) far above what food provides. People with kidney disease should not take it without medical advice.

When we discuss supplements, we describe the forms and doses studies used, the evidence grade and the main safety issues. Any supplement can interact with medicines, so ask a doctor or pharmacist first, especially if you are pregnant, breastfeeding, take medication or have a health condition.

What this framework can’t do

  • Nutrition research is messy. People don’t eat single nutrients, diet is tangled up with income, genes and lifestyle, and diet trials struggle with blinding (there is no placebo salad), adherence and long timescales.
  • People differ. Genes such as APOE4 or MTHFR variants, gut bacteria, age, starting nutrient levels and health conditions all change how a person responds. Our ratings describe what helps most people in most studies.
  • This is not medical treatment. The site gives general dietary information. It is not a substitute for medical advice, diagnosis or treatment. If you have a neurological or psychiatric condition, work with qualified health professionals.
  • Evidence changes. We revise ratings as new meta-analyses and large trials appear. An article reflects the best evidence on the day it was written.

Frequently asked questions

Is the Pro-Cognitive Diet a meal plan?

No. It is a set of principles for judging foods, not a fixed menu. We say which foods to emphasize and which to limit; how you build meals depends on your tastes, culture and budget. It fits many patterns, including Mediterranean, MIND, pescatarian and omnivorous diets.

Can it help with conditions like ADHD or depression?

It underpins our condition articles. ADHD involves dopamine and noradrenaline systems, so we look at protein foods that supply tyrosine, plus iron, zinc and omega-3s. Depression involves serotonin and inflammation, pointing to tryptophan-rich foods, omega-3s (especially EPA) and anti-inflammatory diets. Diet is not a substitute for the treatment a doctor prescribes; discuss changes with your care team, and do not stop or reduce medication on your own.

How often do you update ratings?

We update articles when important new evidence appears, especially new meta-analyses or large trials that shift the balance. Major updates are noted in the relevant articles. Our aim is to reflect current evidence, not defend earlier positions.

Sources

  • Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Bennett, D. A., & Aggarwal, N. T. (2015). MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimer’s & Dementia, 11(9), 1007–1014. doi:10.1016/j.jalz.2014.11.009

  • Barnes, L. L., Dhana, K., Liu, X., Carey, V. J., Ventrelle, J., Johnson, K., … & Sacks, F. M. (2023). Trial of the MIND diet for prevention of cognitive decline in older persons. New England Journal of Medicine, 389(7), 602–611. doi:10.1056/NEJMoa2302368

  • Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014). Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLOS ONE, 9(5), e96905. doi:10.1371/journal.pone.0096905

  • Liao, Y., Xie, B., Zhang, H., He, Q., Guo, L., Subramanieapillai, M., … & McIntyre, R. S. (2019). Efficacy of omega-3 PUFAs in depression: a meta-analysis. Translational Psychiatry, 9(1), 190. doi:10.1038/s41398-019-0515-5

  • Yurko-Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A., … & Stedman, M. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer’s & Dementia, 6(6), 456–464. doi:10.1016/j.jalz.2010.01.013

  • Zeisel, S. H., & da Costa, K. A. (2009). Choline: an essential nutrient for public health. Nutrition Reviews, 67(11), 615–623. doi:10.1111/j.1753-4887.2009.00246.x

  • Gómez-Pinilla, F. (2008). Brain foods: the effects of nutrients on brain function. Nature Reviews Neuroscience, 9(7), 568–578. doi:10.1038/nrn2421

  • Spencer, J. P. E. (2010). The impact of fruit flavonoids on memory and cognition. British Journal of Nutrition, 104(S3), S40–S47. doi:10.1017/S0007114510003934

  • Bourre, J. M. (2006). Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. The Journal of Nutrition, Health & Aging, 10(5), 377–385. PMID:17066209

  • Martínez-Lapiscina, E. H., Clavero, P., Toledo, E., Estruch, R., Salas-Salvadó, J., San Julián, B., … & Martinez-Gonzalez, M. A. (2013). Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. Journal of Neurology, Neurosurgery & Psychiatry, 84(12), 1318–1325. doi:10.1136/jnnp-2012-304792

  • Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., … & Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413–446. doi:10.1016/S0140-6736(20)30367-6

  • Lane, M. M., Gamage, E., Du, S., Ashtree, D. N., McGuinness, A. J., Gauci, S., … & Marx, W. (2024). Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ, 384, e077310. doi:10.1136/bmj-2023-077310

  • Li, H., Li, S., Yang, H., Zhang, Y., Zhang, S., Ma, Y., … & Wang, Y. (2022). Association of ultraprocessed food consumption with risk of dementia: a prospective cohort study. Neurology, 99(10), e1056–e1066. doi:10.1212/WNL.0000000000200871

  • Gomes Gonçalves, N., Vidal Ferreira, N., Khandpur, N., Martinez Steele, E., Bertazzi Levy, R., Andrade Lotufo, P., … & Suemoto, C. K. (2023). Association between consumption of ultraprocessed foods and cognitive decline. JAMA Neurology, 80(2), 142–150. doi:10.1001/jamaneurol.2022.4397

  • Vauzour, D., Camprubi-Robles, M., Miquel-Kergoat, S., Andres-Lacueva, C., Bánáti, D., Barberger-Gateau, P., … & Ramirez, M. (2017). Nutrition for the ageing brain: towards evidence for an optimal diet. Ageing Research Reviews, 35, 222–240. doi:10.1016/j.arr.2016.09.010

  • Sarris, J., Logan, A. C., Akbaraly, T. N., Amminger, G. P., Balanzá-Martínez, V., Freeman, M. P., … & Jacka, F. N. (2015). Nutritional medicine as mainstream in psychiatry. The Lancet Psychiatry, 2(3), 271–274. doi:10.1016/S2215-0366(14)00051-0

  • Mattson, M. P., Moehl, K., Ghena, N., Schmaedick, M., & Cheng, A. (2018). Intermittent metabolic switching, neuroplasticity and brain health. Nature Reviews Neuroscience, 19(2), 63–80. doi:10.1038/nrn.2017.156

  • Devore, E. E., Kang, J. H., Breteler, M. M. B., & Grodstein, F. (2012). Dietary intakes of berries and flavonoids in relation to cognitive decline. Annals of Neurology, 72(1), 135–143. doi:10.1002/ana.23594